Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing precisely dextromethorphan hydrobromide 30 milligram and guaifenesin 600 milligram/1 each prolonged-release oral tablet (clinical drug) |
Plays role |
False |
Antitussive therapeutic role (role) |
Inferred relationship |
Some |
|
Hydrocodone bitartrate 500 microgram/mL and paracetamol 21.7 mg/mL oral solution |
Plays role |
False |
Antitussive therapeutic role (role) |
Inferred relationship |
Some |
|
Product containing precisely hydrocodone bitartrate 333 microgram/1 milliliter and paracetamol 33.3 milligram/1 milliliter conventional release oral solution (clinical drug) |
Plays role |
False |
Antitussive therapeutic role (role) |
Inferred relationship |
Some |
|
Product containing precisely hydrocodone bitartrate 500 microgram/1 milliliter and paracetamol 33.3 milligram/1 milliliter conventional release oral solution (clinical drug) |
Plays role |
False |
Antitussive therapeutic role (role) |
Inferred relationship |
Some |
|
Product containing bromazine and codeine in oral dose form (medicinal product form) |
Plays role |
False |
Antitussive therapeutic role (role) |
Inferred relationship |
Some |
|
Brompheniramine- and dextromethorphan- and pseudoephedrine-containing product in oral dose form |
Plays role |
False |
Antitussive therapeutic role (role) |
Inferred relationship |
Some |
|
Brompheniramine- and codeine- and phenylpropanolamine-containing product in oral dose form |
Plays role |
False |
Antitussive therapeutic role (role) |
Inferred relationship |
Some |
|
Product containing brompheniramine and dextromethorphan and phenylpropanolamine in oral dose form (medicinal product form) |
Plays role |
False |
Antitussive therapeutic role (role) |
Inferred relationship |
Some |
|
Product containing carbinoxamine and dextromethorphan and pseudoephedrine in oral dose form (medicinal product form) |
Plays role |
False |
Antitussive therapeutic role (role) |
Inferred relationship |
Some |
|
Product containing codeine and kaolin in oral dose form (medicinal product form) |
Plays role |
False |
Antitussive therapeutic role (role) |
Inferred relationship |
Some |
|
Product containing codeine and phenylephrine and promethazine in oral dose form (medicinal product form) |
Plays role |
False |
Antitussive therapeutic role (role) |
Inferred relationship |
Some |
|
Codeine- and promethazine-containing product in oral dose form |
Plays role |
False |
Antitussive therapeutic role (role) |
Inferred relationship |
Some |
|
Dextromethorphan-containing product in oromucosal dose form |
Plays role |
False |
Antitussive therapeutic role (role) |
Inferred relationship |
Some |
|
Product containing dextromethorphan in oral dose form (medicinal product form) |
Plays role |
False |
Antitussive therapeutic role (role) |
Inferred relationship |
Some |
|
Product containing dextromethorphan and promethazine in oral dose form (medicinal product form) |
Plays role |
False |
Antitussive therapeutic role (role) |
Inferred relationship |
Some |
|
Dextromethorphan- and guaifenesin-containing product in oral dose form |
Plays role |
False |
Antitussive therapeutic role (role) |
Inferred relationship |
Some |
|
Product containing only bromazine and codeine in oral dose form (medicinal product form) |
Plays role |
False |
Antitussive therapeutic role (role) |
Inferred relationship |
Some |
|
Brompheniramine- and dextromethorphan- and phenylpropanolamine-containing product |
Plays role |
False |
Antitussive therapeutic role (role) |
Inferred relationship |
Some |
|
Brompheniramine- and dextromethorphan- and pseudoephedrine-containing product |
Plays role |
False |
Antitussive therapeutic role (role) |
Inferred relationship |
Some |
|
Carbinoxamine and dextromethorphan and pseudoephedrine only product in oral dose form |
Plays role |
False |
Antitussive therapeutic role (role) |
Inferred relationship |
Some |
|
Codeine and kaolin only product in oral dose form |
Plays role |
False |
Antitussive therapeutic role (role) |
Inferred relationship |
Some |
|
Product containing only codeine and phenylephrine and promethazine in oral dose form (medicinal product form) |
Plays role |
False |
Antitussive therapeutic role (role) |
Inferred relationship |
Some |
|
Product containing only dextromethorphan and guaifenesin in oral dose form (medicinal product form) |
Plays role |
False |
Antitussive therapeutic role (role) |
Inferred relationship |
Some |
|
Dextromethorphan and promethazine only product in oral dose form |
Plays role |
False |
Antitussive therapeutic role (role) |
Inferred relationship |
Some |
|
Product containing only dextromethorphan in oromucosal dose form (medicinal product form) |
Plays role |
False |
Antitussive therapeutic role (role) |
Inferred relationship |
Some |
|
Product containing only brompheniramine and codeine and phenylpropanolamine in oral dose form (medicinal product form) |
Plays role |
False |
Antitussive therapeutic role (role) |
Inferred relationship |
Some |
|
Product containing only brompheniramine and dextromethorphan and phenylpropanolamine (medicinal product) |
Plays role |
False |
Antitussive therapeutic role (role) |
Inferred relationship |
Some |
|
Product containing only brompheniramine and dextromethorphan and phenylpropanolamine in oral dose form (medicinal product form) |
Plays role |
False |
Antitussive therapeutic role (role) |
Inferred relationship |
Some |
|
Product containing only brompheniramine and dextromethorphan and pseudoephedrine (medicinal product) |
Plays role |
False |
Antitussive therapeutic role (role) |
Inferred relationship |
Some |
|
Product containing only brompheniramine and dextromethorphan and pseudoephedrine in oral dose form (medicinal product form) |
Plays role |
False |
Antitussive therapeutic role (role) |
Inferred relationship |
Some |
|
Product containing only codeine and promethazine in oral dose form (medicinal product form) |
Plays role |
False |
Antitussive therapeutic role (role) |
Inferred relationship |
Some |
|
Product containing precisely codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
Plays role |
False |
Antitussive therapeutic role (role) |
Inferred relationship |
Some |
|
Product containing precisely codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release effervescent oral tablet (clinical drug) |
Plays role |
False |
Antitussive therapeutic role (role) |
Inferred relationship |
Some |
|
Product containing precisely codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug) |
Plays role |
False |
Antitussive therapeutic role (role) |
Inferred relationship |
Some |
|
Dibunate-containing product in oral dose form |
Plays role |
False |
Antitussive therapeutic role (role) |
Inferred relationship |
Some |
|
Levocloperastine-containing product |
Plays role |
False |
Antitussive therapeutic role (role) |
Inferred relationship |
Some |
|
Product containing only levocloperastine (medicinal product) |
Plays role |
False |
Antitussive therapeutic role (role) |
Inferred relationship |
Some |
|
Product containing only levocloperastine in oral dose form (medicinal product form) |
Plays role |
False |
Antitussive therapeutic role (role) |
Inferred relationship |
Some |
|
Levocloperastine fendizoate 7.08 mg/mL oral suspension |
Plays role |
False |
Antitussive therapeutic role (role) |
Inferred relationship |
Some |
|
Product containing levocloperastine in oral dose form (medicinal product form) |
Plays role |
False |
Antitussive therapeutic role (role) |
Inferred relationship |
Some |
|
Acetaminophen 500 mg and caffeine 30 mg and codeine phosphate 8 mg oral capsule |
Plays role |
False |
Antitussive therapeutic role (role) |
Inferred relationship |
Some |
|
Product containing precisely codeine phosphate 15 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug) |
Plays role |
False |
Antitussive therapeutic role (role) |
Inferred relationship |
Some |
|
Product containing only dextromethorphan and paracetamol and promethazine in oral dose form (medicinal product form) |
Plays role |
False |
Antitussive therapeutic role (role) |
Inferred relationship |
Some |
|
Product containing only dextromethorphan and paracetamol and promethazine (medicinal product) |
Plays role |
False |
Antitussive therapeutic role (role) |
Inferred relationship |
Some |
|
Dextromethorphan- and paracetamol- and promethazine-containing product |
Plays role |
False |
Antitussive therapeutic role (role) |
Inferred relationship |
Some |
|
Dextromethorphan- and paracetamol- and promethazine-containing product in oral dose form |
Plays role |
False |
Antitussive therapeutic role (role) |
Inferred relationship |
Some |
|
Product containing precisely dextromethorphan hydrobromide 7.5 milligram and paracetamol 500 milligram and promethazine hydrochloride 10 milligram/1 each conventional release oral capsule (clinical drug) |
Plays role |
False |
Antitussive therapeutic role (role) |
Inferred relationship |
Some |
|
Product containing precisely dextromethorphan 2 milligram/1 milliliter and pseudoephedrine hydrochloride 6 milligram/1 milliliter and triprolidine hydrochloride 250 microgram/1 milliliter conventional release oral solution (clinical drug) |
Plays role |
False |
Antitussive therapeutic role (role) |
Inferred relationship |
Some |
|
Product containing only dextromethorphan and pseudoephedrine and triprolidine (medicinal product) |
Plays role |
False |
Antitussive therapeutic role (role) |
Inferred relationship |
Some |
|
Product containing dextromethorphan and pseudoephedrine and triprolidine (medicinal product) |
Plays role |
False |
Antitussive therapeutic role (role) |
Inferred relationship |
Some |
|
Product containing only dextromethorphan and pseudoephedrine and triprolidine in oral dose form (medicinal product form) |
Plays role |
False |
Antitussive therapeutic role (role) |
Inferred relationship |
Some |
|
Dextromethorphan- and pseudoephedrine- and triprolidine-containing product in oral dose form |
Plays role |
False |
Antitussive therapeutic role (role) |
Inferred relationship |
Some |
|
Product containing precisely dextromethorphan hydrobromide 750 microgram/1 milliliter and paracetamol 50 milligram/1 milliliter and promethazine hydrochloride 1 milligram/1 milliliter conventional release oral solution (clinical drug) |
Plays role |
False |
Antitussive therapeutic role (role) |
Inferred relationship |
Some |
|
Product containing precisely dextromethorphan hydrobromide 1.3 milligram/1 milliliter and diphenhydramine hydrochloride 2.8 milligram/1 milliliter and levomenthol 400 microgram/1 milliliter conventional release oral solution (clinical drug) |
Plays role |
False |
Antitussive therapeutic role (role) |
Inferred relationship |
Some |
|
Product containing dextromethorphan and diphenhydramine and levomenthol in oral dose form (medicinal product form) |
Plays role |
False |
Antitussive therapeutic role (role) |
Inferred relationship |
Some |
|
Product containing only dextromethorphan and diphenhydramine and levomenthol in oral dose form (medicinal product form) |
Plays role |
False |
Antitussive therapeutic role (role) |
Inferred relationship |
Some |
|
Product containing dextromethorphan and diphenhydramine and levomenthol (medicinal product) |
Plays role |
False |
Antitussive therapeutic role (role) |
Inferred relationship |
Some |
|
Dextromethorphan and diphenhydramine and levomenthol only product |
Plays role |
False |
Antitussive therapeutic role (role) |
Inferred relationship |
Some |
|
Buclizine hydrochloride 6.25 mg and codeine phosphate 8 mg and paracetamol 500 mg oral tablet |
Plays role |
False |
Antitussive therapeutic role (role) |
Inferred relationship |
Some |
|
Buclizine- and codeine- and paracetamol-containing product in oral dose form |
Plays role |
False |
Antitussive therapeutic role (role) |
Inferred relationship |
Some |
|
Product containing only buclizine and codeine and paracetamol in oral dose form (medicinal product form) |
Plays role |
False |
Antitussive therapeutic role (role) |
Inferred relationship |
Some |
|
Product containing precisely caffeine 30 milligram and codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
Plays role |
False |
Antitussive therapeutic role (role) |
Inferred relationship |
Some |
|